Integrating Genetics and Proteomics for Drug Discovery

  • 669

    Total downloads

  • 3,436

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 29 December 2024 | Manuscript Extension Submission Deadline 19 January 2025

Background

In the past decades, quickly evolving sequencing technology accompanied with big data in computational science has driven a lot of novel medical applications, especially enabling the discovery of associations and causalities. Genome-wide association study (GWAS) have identified thousands of genomic variants associated with biological traits of diseases and used to predict disease risk. Furthermore, high throughput genomic sequencing technology boosts such applications into unprecedented scale.

In parallel, proteomics-driven biomarker discovery is essential to explore dysregulated pathways that ultimately cause disease. Despite the central importance of proteins in disease biology, large-scale analyses of proteomic data are only now becoming more feasible, largely due to the technical challenges of profiling proteins in a proteome-wide, populational-scale manner. The proteomics community is constantly seeking methods that could quantify whole-proteome containing thousands of proteins across a wide dynamic range in thousands of samples, while minimising the requirement of sample amount, data acquisition time, and the analysis time needed. Recent progress of mass spectrometry (MS) based approach using data-independent acquisition (DIA), immune-affinity based approach like Olink, and aptamer-based method like SomaScan provides promising insight into human biology.

Proteins promote key functions in all biological processes and serve as an intermediate of how genetic risk factors could be linked to clinical outcomes. Thus, associations between multiple layers of molecular information, such as protein expression and DNA sequence variants that correlate with risk alleles for common diseases can expose disease-associated pathways, revealing novel drug targets and translational biomarkers.

Integrating proteomics with genetic information has been an emerging strategy for research and the pharmaceutical industry. For example, protein quantitative trait loci (pQTL) studies identify genetic variants that regulate protein expression and offer a route to a comprehensive molecular interpretation of disease GWAS hits. On the other hand, proteogenomics utilises an approach to customise protein sequence databases generated using genomic and transcriptomic information. Thanks to drastic improvement of the depths and throughput of next generation sequencing (NGS), MS based proteomics, as well as novel artificial intelligence (AI) based computational methodologies, proteogenomics is promising to help identify novel peptides that are not represented in the “classical” proteome reference sequence database.

From an “omics” perspective, the research and medical field were historically dominated by single modality alone. While genomics and proteomics still have a lot of their own challenges and high potential to work with, we expect integrative system biology approaches can illuminate the complex biology that is either difficult to obtain or not possible through standalone regime, helping make precision medicine more precise and drug discovery more druggable.

This Research Topic will accept submissions of the following article types: Brief Research Reports, Clinical Trials, General Commentaries, Hypothesis & Theory, Methods, Mini Reviews, Opinion, Original Research, Perspectives, Reviews, and Systematic Reviews. Specific topics to be addressed include, but are not limited to:

- Genomics and/or Proteomics based discovery of new drugs and vaccines

- Genomics and/or proteomics driven biomarker discovery, diagnosis, mechanism or action, etc.

- MultiOmics approach to investigate disease-associated pathways, revealing novel drug targets and translational biomarkers

- New proteogenomics approach to improve proteomics application like research and precision medicine

- Computational and bioinformatic method for discovery of associations and causalities in human disease

- AI/ML based approach to integrate high dimensional genomic and proteomics information

Please note: If patient data are analysed, a comprehensive description of the patients including sex, age, diagnostic criteria, inclusion and exclusion criteria, disease stage, therapy received, comorbidities as well as additional clinical information and assessment of clinical response/effects should be included. If genetic, proteomics, metabolomics, or other omics data are analysed, a comprehensive description of the methods and the rationale for the selection of the specific data studied should be provided. Studies related to natural compounds, herbal extracts, or traditional medicine products, are outside the scope of this Research Topic and should instead be submitted to the specialty section Ethnopharmacology.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Data Report
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Genetics, Proteomics, GWAS, drug discovery, translational biomarkers

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 3,436Topic views
  • 1,738Article views
  • 669Article downloads
View impact